| Id |
Subject |
Object |
Predicate |
Lexical cue |
| T117 |
0-10 |
Sentence |
denotes |
Discussion |
| T118 |
11-73 |
Sentence |
denotes |
CRS is characterized by high levels of inflammatory cytokines. |
| T119 |
74-156 |
Sentence |
denotes |
Among them, IL-6 is considered a major mediator of this hyperinflammation [18,19]. |
| T120 |
157-265 |
Sentence |
denotes |
Most of the COVID-19 patients-related papers showed the CRS as one of the main hallmark of the disease [20]. |
| T121 |
266-335 |
Sentence |
denotes |
Additionally, IL-6 levels predict severity in COVID-19 patients [21]. |
| T122 |
336-438 |
Sentence |
denotes |
There is high heterogeneity of IL-6 values among papers for classifying severe and nonsevere patients. |
| T123 |
439-586 |
Sentence |
denotes |
In a large meta-analysis of 52 manuscripts, Elshazli and coworkers found that the IL-6 level associated with COVID-19 severity was 22.9 pg/ml [22]. |
| T124 |
587-750 |
Sentence |
denotes |
In a series of patients treated with itolizumab a cutoff of 28 pg/ml discriminates severe patients from nonsevere (manuscript just accepted in Immunity and Aging). |
| T125 |
751-840 |
Sentence |
denotes |
In the present study, the IL-6 concentration of the three patients was above this cutoff. |
| T126 |
841-939 |
Sentence |
denotes |
It confirms the classification of these patients as severe and that the CRS is probably occurring. |
| T127 |
940-1051 |
Sentence |
denotes |
Several anticytokine therapies have been tried for treating the hyperinflammatory phase of COVID-19 [20,23–25]. |
| T128 |
1052-1179 |
Sentence |
denotes |
Here, we report the use of a well-known anti-inflammatory antibody targeting CD6 to treat the CRS arising in COVID-19 patients. |
| T129 |
1180-1411 |
Sentence |
denotes |
Using an anti-CD6 antibody could reduce the concentration of several pro-inflammatory cytokines, including IL-6, IFN-γ, TNF-α and IL-17, among others, representing an advantage as compared with single-cytokine targeting antibodies. |
| T130 |
1412-1537 |
Sentence |
denotes |
The antibody would not exacerbate lymphopenia since it does not induce complement or antibody dependent cytotoxicity [10,11]. |
| T131 |
1538-1655 |
Sentence |
denotes |
These three SARS-CoV2 patients developed severe respiratory distress together with multifocal interstitial pneumonia. |
| T132 |
1656-1760 |
Sentence |
denotes |
Two patients required invasive mechanical ventilation while the third patient only needed oxygen supply. |
| T133 |
1761-1946 |
Sentence |
denotes |
They all received the anti-CD6 antibody itolizumab in combination with other drugs incorporated into the Cuban national protocol, including lopinavir/ritonavir, chloroquine and IFNα-2b. |
| T134 |
1947-2105 |
Sentence |
denotes |
Regarding to laboratory parameters, AST is strongly associated with mortality risk compared with other parameters, reflecting liver and kidney injury [26,27]. |
| T135 |
2106-2274 |
Sentence |
denotes |
In our cases, critically ill patients showed a significant reduction of AST concentration after the treatment suggesting an improvement in the function of these organs. |
| T136 |
2275-2366 |
Sentence |
denotes |
Itolizumab was very safe and did not seem to exacerbate opportunistic secondary infections. |
| T137 |
2367-2492 |
Sentence |
denotes |
Unfortunately, we did no measure neither the frequency nor the total amount of circulating T cells in these initial patients. |
| T138 |
2493-2590 |
Sentence |
denotes |
The impact of itolizumab on circulating T cells are being implementing in new recruited patients. |
| T139 |
2591-2772 |
Sentence |
denotes |
Our preliminary findings support that IL-6 levels correlated with the severity of the disease and that the antibody was capable of reducing IL-6 concentration in all three subjects. |
| T140 |
2773-2852 |
Sentence |
denotes |
One patient died after subsequent respiratory and cardiovascular complications. |
| T141 |
2853-2957 |
Sentence |
denotes |
In this particular case, IL-6 concentration was extremely elevated at the moment of itolizumab infusion. |
| T142 |
2958-3075 |
Sentence |
denotes |
Although, the levels of IL-6 decreased during treatment, the values at 7 days kept still very high (above 300 pg/ml). |
| T143 |
3076-3156 |
Sentence |
denotes |
There was a transient improvement of respiratory function but it was not enough. |
| T144 |
3157-3370 |
Sentence |
denotes |
Presumably, the consequences of the hyperinflammatory syndrome (thrombosis, alveolar damage and severe tissue hypoxia) were irreversible at the moment of treatment and patient died as consequence of these factors. |